Park Avenue Securities’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-9,050
| Closed | -$232K | – | 1465 |
|
|
2024
Q3 | $232K | Sell |
9,050
-1,615
| -15% | -$41.4K | ﹤0.01% | 1286 |
|
|
2024
Q2 | $250K | Sell |
10,665
-1,002
| -9% | -$23.5K | ﹤0.01% | 1240 |
|
|
2024
Q1 | $336K | Buy |
11,667
+1,435
| +14% | +$41.3K | ﹤0.01% | 1135 |
|
|
2023
Q4 | $336K | Buy |
10,232
+203
| +2% | +$6.67K | ﹤0.01% | 1071 |
|
|
2023
Q3 | $279K | Buy |
+10,029
| New | +$279K | ﹤0.01% | 1078 |
|
|
2023
Q2 | – | Sell |
-11,611
| Closed | -$349K | – | 723 |
|
|
2023
Q1 | $349K | Sell |
11,611
-2,110
| -15% | -$63.4K | 0.01% | 649 |
|
|
2022
Q4 | $387K | Sell |
13,721
-2,101
| -13% | -$59.3K | 0.01% | 874 |
|
|
2022
Q3 | $520K | Buy |
15,822
+2,139
| +16% | +$70.3K | 0.01% | 696 |
|
|
2022
Q2 | $431K | Sell |
13,683
-940
| -6% | -$29.6K | 0.01% | 756 |
|
|
2022
Q1 | $672K | Buy |
14,623
+373
| +3% | +$17.1K | 0.01% | 618 |
|
|
2021
Q4 | $873K | Buy |
14,250
+7,271
| +104% | +$445K | 0.02% | 523 |
|
|
2021
Q3 | $521K | Buy |
6,979
+4,222
| +153% | +$315K | 0.01% | 617 |
|
|
2021
Q2 | $255K | Buy |
+2,757
| New | +$255K | 0.01% | 906 |
|